CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...
Phase 2
Jacksonville, Florida, United States and 44 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Jacksonville, Florida, United States and 131 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC) or non-sma...
Phase 1
Jacksonville, Florida, United States and 17 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Jacksonville, Florida, United States and 275 other locations
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...
Phase 1
Fleming Island, Florida, United States and 39 other locations
does to the body besides treating the disease.Participants will have cancer that has spread in the body near where it started (locally advan...
Phase 1
Jacksonville, Florida, United States and 17 other locations
The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumors
Phase 1, Phase 2
Fleming Island, Florida, United States and 65 other locations
The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...
Phase 1, Phase 2
Jacksonville, Florida, United States and 56 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), end...
Phase 1, Phase 2
Jacksonville, Florida, United States and 123 other locations
receptor-low/HER2-negative breast cancer....
Phase 3
Jacksonville, Florida, United States and 338 other locations
Clinical trials
Research sites
Resources
Legal